Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | HTR1A | P08908 | 1/20 | 0.61 |
| ▸ | HTR2C | P28335 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA4 | P22748 | 2/20 | 0.45 |
| ▸ | CA6 | P23280 | 2/20 | 0.45 |
| ▸ | CA5A | P35218 | 2/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL976533 | 0.88 | PKM (0.58) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| SCHEMBL3789794 | 0.87 | KDM4E (0.65) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| SCHEMBL3789790 | 0.87 | KDM4E (0.65) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| SCHEMBL28562989 | 0.83 | KDM4E (0.59) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| SCHEMBL28562986 | 0.83 | KDM4E (0.59) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| SCHEMBL6852555 | 0.81 | NFE2L2 (0.69) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| SCHEMBL6852559 | 0.81 | NFE2L2 (0.69) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| SCHEMBL28630448 | 0.81 | PKM (0.61) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| SCHEMBL12672381 | 0.79 | KDM4E (0.64) | KDM4EALDH1A1HPGDHSD17B10HTR1A | |
| SCHEMBL14966221 | 0.79 | KDM4E (0.55) | KDM4EALDH1A1HPGDHSD17B10HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116920094-A | Use of Bufinager (BN-29) for the treatment of pneumonia caused by human coronavirus 229E infection | 内蒙古医科大学 | 2023-10-24 | — | — | CN | claimed |
| CN-116920094-A | Use of Bufinager (BN-29) for the treatment of pneumonia caused by human coronavirus 229E infection | 内蒙古医科大学 | 2023-10-24 | — | — | CN | disclosed |
| CN-116920094-A | Use of Bufinager (BN-29) for the treatment of pneumonia caused by human coronavirus 229E infection | 内蒙古医科大学 | 2023-10-24 | — | — | CN | disclosed |
| CN-114515292-B | Application of 3,6' -dibapinyl sucrose ester in preparing medicine for treating anxiety | 北京中医药大学 | 2023-04-07 | — | — | CN | disclosed |
| EP-3225616-B1 | ALPHA-ASARY-LALDEHYDE ESTER, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | UNIV NORTHWEST (CN) | 2020-03-04 | — | — | EP | disclosed |
| US-10131619-B2 | α-Asary-laldehyde ester, preparation method therefor, and application thereof | NORTHWEST UNIVERSITY (CN) | 2018-11-20 | — | — | US | disclosed |
| EP-3225616-A1 | ALPHA-ASARY-LALDEHYDE ESTER, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Northwest University (CN) | 2017-10-04 | — | — | EP | disclosed |
| US-20170260122-A1 | a-ASARY-LALDEHYDE ESTER, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | NORTHWEST UNIVERSITY (CN) | 2017-09-14 | — | — | US | disclosed |
| CN-107050100-A | Red stilbene Chinese medicine is taken after being infused in hot water or decoction medicine materical crude slice | 江苏苏轩堂药业有限公司 | 2017-08-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10131619-B2 | α-Asary-laldehyde ester, preparation method therefor, and application thereof | ALDH7A1, LSS, CYP51A1 | KDM4E 2585/4885ALDH1A1 4/4885HPGD 121/4885 |
| US-20170260122-A1 | a-ASARY-LALDEHYDE ESTER, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | LSS, CYP51A1, BACE1 | KDM4E 509/4885ALDH1A1 49/4885HPGD 709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.